UBS Group AG - AQUESTIVE THERAPEUTICS INC ownership

AQUESTIVE THERAPEUTICS INC's ticker is AQST and the CUSIP is 03843E104. A total of 47 filers reported holding AQUESTIVE THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 2.1%.

Quarter-by-quarter ownership
UBS Group AG ownership history of AQUESTIVE THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$4,268
-61.2%
3,744
-58.7%
0.00%
Q3 2022$11,0009,068
+2085.1%
0.00%
Q2 2022$0
-100.0%
415
-49.9%
0.00%
Q1 2022$2,000
-75.0%
829
-57.7%
0.00%
Q4 2021$8,000
-81.8%
1,959
-80.4%
0.00%
Q3 2021$44,000
-21.4%
10,000
-28.9%
0.00%
Q2 2021$56,000
-24.3%
14,060
-0.8%
0.00%
Q1 2021$74,000
-42.2%
14,174
-40.4%
0.00%
Q4 2020$128,000
+88.2%
23,769
+68.6%
0.00%
Q3 2020$68,000
-63.2%
14,100
-63.0%
0.00%
Q2 2020$185,000
+340.5%
38,081
+98.5%
0.00%
Q1 2020$42,000
-27.6%
19,188
+91.9%
0.00%
Q4 2019$58,000
+81.2%
10,0000.0%0.00%
Q3 2019$32,000
-23.8%
10,0000.0%0.00%
Q2 2019$42,000
-54.3%
10,000
-24.9%
0.00%
Q1 2019$92,000
+300.0%
13,322
+905.4%
0.00%
Q3 2018$23,0001,3250.00%
Other shareholders
AQUESTIVE THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Bratton Capital Management, L.P. 9,810,958$16,188,081100.00%
Vahanian & Associates Financial Planning Inc. 725,208$1,196,5933.78%
Bracebridge Capital, LLC 428,571$707,1420.39%
Latash Investments, LLC 243,134$401,1710.32%
XTX Topco Ltd 138,145$227,9390.04%
ARMISTICE CAPITAL, LLC 1,158,000$1,910,7000.03%
OCCUDO QUANTITATIVE STRATEGIES LP 84,355$139,1860.01%
Hillsdale Investment Management Inc. 66,600$109,8900.01%
D.B. Root & Company, LLC 12,950$21,3680.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 147,856$243,9620.01%
View complete list of AQUESTIVE THERAPEUTICS INC shareholders